NeuroPace (NPCE) News Today $9.52 -0.65 (-6.39%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$9.62 +0.10 (+1.00%) As of 07/11/2025 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NPCE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period NeuroPace’s SWOT analysis: innovative epilepsy treatment stock faces growth hurdles - Investing.comJuly 8, 2025 | investing.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. ...July 6, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEJuly 2, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEJune 27, 2025 | prnewswire.comNeuroPace Announces Strategic CFO Transition - MorningstarJune 26, 2025 | morningstar.comMNeuroPace, Inc.: NeuroPace Announces Strategic CFO TransitionJune 25, 2025 | finanznachrichten.deINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE - MorningstarJune 24, 2025 | morningstar.comMNeuroPace Announces Strategic CFO TransitionJune 24, 2025 | globenewswire.comNPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law FirmJune 24, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEJune 23, 2025 | globenewswire.comPalumbo Wealth Management LLC Has $567,000 Holdings in NeuroPace, Inc. (NASDAQ:NPCE)June 23, 2025 | marketbeat.comNPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law FirmJune 22, 2025 | gurufocus.comNPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law FirmJune 22, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. ...June 22, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEJune 22, 2025 | prnewswire.comNeuroPace, Inc. (NASDAQ:NPCE) Given Consensus Rating of "Moderate Buy" by BrokeragesJune 22, 2025 | marketbeat.comNeuroPace, Inc. (NPCE) Backed by Cantor Fitzgerald Following Physician SurveyJune 17, 2025 | msn.comNeuroPace’s SWOT analysis: med tech stock poised for growth amid challengesJune 14, 2025 | investing.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEJune 12, 2025 | prnewswire.comTwo Sigma Investments LP Makes New Investment in NeuroPace, Inc. (NASDAQ:NPCE)June 11, 2025 | marketbeat.comCantor Fitzgerald Comments on NeuroPace FY2026 EarningsJune 10, 2025 | marketbeat.comQ2 Earnings Forecast for NeuroPace Issued By Leerink PartnrsJune 9, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEJune 7, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEJune 6, 2025 | globenewswire.comNeuroPace, Inc. Secures $75 Million Credit Facility from MidCap Financial to Support Growth InitiativesJune 5, 2025 | nasdaq.comNeuroPace Secures $75 Million Credit Facility with MidCapJune 4, 2025 | tipranks.comNeuroPace Secures Up to $75 Million in Debt FinancingJune 4, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeuroPace, Inc. - NPCEJune 2, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. ...June 1, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEJune 1, 2025 | prnewswire.comWhat is Leerink Partnrs' Estimate for NeuroPace Q3 Earnings?May 31, 2025 | marketbeat.comQ2 Earnings Estimate for NeuroPace Issued By HC WainwrightMay 31, 2025 | marketbeat.comLeerink Partnrs Reduces Earnings Estimates for NeuroPaceMay 30, 2025 | marketbeat.comH.C. Wainwright Initiates Coverage of NeuroPace (NPCE) With Buy RatingMay 30, 2025 | msn.comNeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Rating of "Moderate Buy" from BrokeragesMay 29, 2025 | marketbeat.comNeuroPace (NASDAQ:NPCE) Earns Buy Rating from Analysts at HC WainwrightMay 29, 2025 | marketbeat.com6NPCE : Analyst Expectations For NeuroPace's FutureMay 29, 2025 | benzinga.comHC Wainwright & Co. Initiates Coverage of NeuroPace (NPCE) with Buy RecommendationMay 29, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEMay 28, 2025 | globenewswire.comMillennium Management LLC Sells 96,782 Shares of NeuroPace, Inc. (NASDAQ:NPCE)May 28, 2025 | marketbeat.comNeuroPace, Inc.: NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS StudyMay 27, 2025 | finanznachrichten.deNeuroPace stock sinks following clinical study resultsMay 27, 2025 | za.investing.comNeuroPace Shares Plunge After Mixed Clinical Trial ResultsMay 27, 2025 | msn.comNeuroPace falls after setback in trial for neuromodulation systemMay 27, 2025 | msn.comWhy Is NeuroPace Stock Falling After Epilepsy Treatment Study Data?May 27, 2025 | benzinga.comNeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS StudyMay 27, 2025 | globenewswire.comNeuroPace, Inc. (NASDAQ:NPCE) Shares Bought by Northern Trust CorpMay 27, 2025 | marketbeat.comPoint72 Asset Management L.P. Invests $369,000 in NeuroPace, Inc. (NASDAQ:NPCE)May 26, 2025 | marketbeat.comNeuroPace (NASDAQ:NPCE) Hits New 52-Week High - What's Next?May 24, 2025 | marketbeat.com100,095 Shares in NeuroPace, Inc. (NASDAQ:NPCE) Acquired by Jane Street Group LLCMay 24, 2025 | marketbeat.com Get NeuroPace News Delivered to You Automatically Sign up to receive the latest news and ratings for NPCE and its competitors with MarketBeat's FREE daily newsletter. Email Address NPCE Media Mentions By Week NPCE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NPCE News Sentiment▼1.371.00▲Average Medical News Sentiment NPCE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NPCE Articles This Week▼33▲NPCE Articles Average Week Get NeuroPace News Delivered to You Automatically Sign up to receive the latest news and ratings for NPCE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Artivion News Cadre News Tandem Diabetes Care News Establishment Labs News Liquidia Technologies News SS Innovations International News Paragon 28 News BioLife Solutions News Pulse Biosciences News Kestra Medical Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NPCE) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroPace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroPace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
